Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.
about
Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brainProof of concept trial of dronabinol in obstructive sleep apnea5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in ratsLooking for the role of cannabinoid receptor heteromers in striatal functionEndocannabinoid signalling in the blood of patients with schizophreniaParsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNSAre cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic reviewImmune mechanisms in cerebral ischemic toleranceCannabinoids and Epilepsy.CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophreniaNoladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissuesAdenosine-cannabinoid receptor interactions. Implications for striatal functionDifferential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptorsThe endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1.Cannabinoids and the gastrointestinal tractDirect inhibition of T-type calcium channels by the endogenous cannabinoid anandamideEvidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cellsForebrain-specific inactivation of Gq/G11 family G proteins results in age-dependent epilepsy and impaired endocannabinoid formationCB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice.Decoding functional metabolomics with docosahexaenoyl ethanolamide (DHEA) identifies novel bioactive signals[Brain effects of cannabis--neuroimaging findings].Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development.Differential role of the nitric oxide pathway on delta(9)-THC-induced central nervous system effects in the mouse.Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain.CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT/glycogen synthase kinase-3beta/beta-catenin signalingBiomarkers of endocannabinoid system activation in severe obesityMotion sickness, stress and the endocannabinoid systemSpatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system.Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors.Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets.Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the FutureComparative biology of the endocannabinoid system possible role in the immune response.Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.Cannabinoid receptors are absent in insects.Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential.Pharmacological actions and therapeutic uses of cannabis and cannabinoids.Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD).Changes in cannabinoid CB(1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis.Endocannabinoids and neuroprotection.
P2860
Q24299523-8D459F9F-73EC-46ED-B24C-6BF6B0E17273Q24631420-897EAABB-2AC3-43CD-9A00-58801C08FF93Q24644922-96E69B9C-F4EF-483F-8FC4-52D13A037D38Q24658338-5519DF79-E44F-409B-B721-AB82BC5724BFQ24800061-E6C8EA0E-546C-4EE2-8D50-2830ED0D188FQ26853436-F3995C50-21D1-4E68-A6D0-D922AFEBA49AQ27005619-E0AD4533-546D-460B-A71E-1A0722679927Q27022067-F3C7B4BF-1744-4116-875D-B6F6687E9212Q27336451-14CC0C54-F2EE-4700-A409-4640988D0AEDQ28206825-E0A6BC7F-EC36-40EC-B19F-83EA8800CB57Q28208218-F6785F97-C188-4A60-9B97-142C7B46E4F7Q28286488-5FC41300-F632-488F-B14A-AF908D896C89Q28346747-B129B06B-6BC4-4B6B-8968-75162AD13F3AQ28354250-E78F0221-44DA-4CB1-A52F-76151A574289Q28365382-69DD4CFD-A7FB-4830-BA42-7BC0FA6F296BQ28366316-1591F8D5-A9B3-4875-8D3B-B1A3155B8E7DQ28378272-738EAAB4-B059-4DA7-8EF1-E16053670A95Q30478061-03F134BE-8BE8-4288-AD74-A743A3E80A1AQ30499515-923E38B8-60D6-4D8B-9E84-ACC2A79C77C0Q30504292-CB30A6A7-F2C4-459F-BD98-7C0383353B25Q30988788-056F1E6B-8C41-4706-BFA6-A103FF7A29BCQ31522100-98917F19-11F6-43F3-B775-FEC49230EA09Q31900735-BAD3EB6B-32D8-4093-9E3F-250963B06A99Q33186390-BF6F0E0A-11AD-465B-A144-DDE7F1790EC4Q33524983-529ECAF2-C15A-483B-B2C7-F586E44C3A2BQ33526312-6E2035D2-7C68-4523-B4F3-1BBC4D0E1A94Q33588600-9507BA49-9845-40AD-8487-0DCB3AC58AA0Q33897801-1364D3E9-44BC-4162-8E1A-BDF33ECABADAQ33918606-26B52EBC-784D-4CD6-9915-0F63CB301D3CQ33940288-5210B98F-23A0-47CF-AFD5-45542EFF311BQ33946795-A655E649-73EA-42A5-9B32-A753137F1E2DQ33980198-1A91B1B1-D1D2-40F4-8B04-B714A6246954Q33994487-BDD19DD3-EC06-4409-B325-2A6D48A5ACB7Q33997873-1ACB27B6-6649-40FD-A8FE-03D217C1077AQ34083619-A7D484E3-3451-46DA-95EE-88C9DBA04921Q34418106-09995548-47E9-4E3A-BAFE-9905BCD52C4CQ34434597-EF6C57C5-855F-48C0-88CB-7A5E8CB162E0Q34461976-64D149B3-B72E-4C4C-AE3E-B2FBE08832FFQ34515581-C03A2B4E-E67A-4976-8DFC-910D2C237DE2Q34611968-C9CE79CF-F948-4AC9-A703-76C7250C61C4
P2860
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.
@en
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.
@nl
type
label
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.
@en
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.
@nl
prefLabel
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.
@en
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.
@nl
P2093
P921
P1476
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.
@en
P2093
De Petrocellis L
P304
P356
10.1016/S0166-2236(98)01283-1
P577
1998-12-01T00:00:00Z